Glaxosmithkline Pharmaceuticals informs about analyst meet

18 Sep 2020 Evaluate
Pursuant to Regulation 30(6) of the Schedule Ill, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed about the details of Analyst or Institutional Meetings with the Company scheduled on 28th September 2020.
The above information is a part of company’s filings submitted to BSE.


Glaxosmithkline Phar Share Price

2279.85 -101.05 (-4.24%)
23-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1756.35
Dr. Reddys Lab 1252.55
Cipla 1222.70
Zydus Lifesciences 860.55
Lupin 2297.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×